Will we be competing with the Avita products. they seem to be getting good press & deals in USA, while showing current availability & pricing? Our FDA trial seems set on "foot ulcers", but surely the treatment will also be approved for other wounds?
Cheers,
Japes.
Ann: VF001 - Clinical Presentation, page-3
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable